How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
- PMID: 16963663
- DOI: 10.1378/chest.130.3.681
How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
Abstract
Background: Patients receiving heparin for thromboprophylaxis or treatment may have new or recurrent venous thromboembolism (VTE) if immune-mediated heparin-induced thrombocytopenia (HIT) occurs or for other reasons, eg, if anticoagulation fails. We estimated from the literature how frequently a patient presenting with VTE during or following heparin therapy has HIT-associated VTE.
Methods: A comprehensive, systematic literature search was conducted to identify studies using unfractionated or low-molecular-weight heparin (LMWH) for thromboprophylaxis or treatment in which new or recurrent VTE and serologically confirmed HIT were reported. From extracted study data, the proportion of patients with HIT-associated VTE relative to any VTE was calculated by heparin type and mode of administration.
Results: We identified 10 studies, some with multiple arms, that used unfractionated heparin (IV administration, 5 studies; subcutaneous administration, 3 studies) or subcutaneous LMWH (5 studies) and met analysis criteria. Across these studies, 386 of 6,219 heparin-treated patients had VTE, including 32 patients who also had HIT. The frequency of HIT-associated VTE among heparin-treated patients with VTE was comparable between IV and subcutaneous unfractionated heparin therapy (13.2% [17 of 129 patients] vs 12.4% [14 of 113 patients]; odds ratio, 1.07; 95% confidence interval, 0.50 to 2.3; p > 0.99) yet significantly different between unfractionated heparin and LMWH therapy (12.8% [31 of 242 patients] vs 0.7% [1 of 144 patients]; odds ratio, 21.0; 95% confidence interval, 2.8 to 156; p < 0.001).
Conclusions: VTE is associated with HIT infrequently (< 1%) in LMWH-treated patients, yet often (approximately one in eight cases) in unfractionated heparin-treated patients. Physicians should suspect the possibility of HIT if VTE develops during or soon after unfractionated heparin use; if thrombocytopenia is present, alternative anticoagulation should be used until HIT is excluded.
Comment in
-
Think of HIT when thrombosis follows heparin.Chest. 2006 Sep;130(3):631-2. doi: 10.1378/chest.130.3.631. Chest. 2006. PMID: 16963651 No abstract available.
Similar articles
-
No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.Chest. 2007 Oct;132(4):1131-9. doi: 10.1378/chest.06-2518. Epub 2007 Jul 23. Chest. 2007. PMID: 17646239
-
Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.Pharmacotherapy. 2006 Oct;26(10):1438-45. doi: 10.1592/phco.26.10.1438. Pharmacotherapy. 2006. PMID: 16999654
-
Evaluation of prophylactic anticoagulation, deep venous thrombosis, and heparin-induced thrombocytopenia in 21 burn centers in Germany, Austria, and Switzerland.Ann Plast Surg. 2011 Jul;67(1):17-24. doi: 10.1097/SAP.0b013e31821bd4bc. Ann Plast Surg. 2011. PMID: 21629067
-
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest. 2004 Sep;126(3 Suppl):338S-400S. doi: 10.1378/chest.126.3_suppl.338S. Chest. 2004. PMID: 15383478 Review.
-
Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?Semin Thromb Hemost. 2004 Feb;30 Suppl 1:11-23. doi: 10.1055/s-2004-822999. Semin Thromb Hemost. 2004. PMID: 15085462 Review.
Cited by
-
Management of venous thromboembolism in patients with cancer: role of dalteparin.Vasc Health Risk Manag. 2008;4(2):279-87. doi: 10.2147/vhrm.s2132. Vasc Health Risk Manag. 2008. PMID: 18561503 Free PMC article. Review.
-
Thromboembolism prophylaxis in orthopaedics: an update.EFORT Open Rev. 2018 Apr 27;3(4):136-148. doi: 10.1302/2058-5241.3.170018. eCollection 2018 Apr. EFORT Open Rev. 2018. PMID: 29780621 Free PMC article.
-
Venous thromboembolic disease.J Natl Compr Canc Netw. 2011 Jul 1;9(7):714-77. doi: 10.6004/jnccn.2011.0062. J Natl Compr Canc Netw. 2011. PMID: 21715723 Free PMC article. No abstract available.
-
Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case series.Thromb J. 2008 Jul 2;6:9. doi: 10.1186/1477-9560-6-9. Thromb J. 2008. PMID: 18597693 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous